Skip to content
10-Q

Quarterly Report

Verrica Pharmaceuticals Inc. VRCA

0001660334-25-000006

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 9.49M sh
Shares Diluted Q3 2025 · Sep 30, 2025 9.49M sh
Shares Diluted Q3 2025 · Sep 30, 2025 9.49M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 4.68M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 4.66M sh
Capex Q3 2025 · Sep 30, 2025 $0
Capex Q3 2025 · Sep 30, 2024 $27K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$13.04M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$44.86M
Long Term Debt Q3 2025 · Sep 30, 2025 $21.62M
Long Term Debt Q3 2025 · Dec 31, 2024 $30.98M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $21.1M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $46.33M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$17.04M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$17.48M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$18.58M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$9.86M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$34.05M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$13.3M
Stockholders Equity Q3 2025 · Mar 31, 2024 $1.51M
Stockholders Equity Q3 2025 · Dec 31, 2023 $19.76M
Current Liabilities Q3 2025 · Sep 30, 2025 $28.91M
Current Liabilities Q3 2025 · Dec 31, 2024 $29.01M
Total Liabilities Q3 2025 · Sep 30, 2025 $57.94M
Total Liabilities Q3 2025 · Dec 31, 2024 $63.99M
Current Assets Q3 2025 · Sep 30, 2025 $36.28M
Current Assets Q3 2025 · Dec 31, 2024 $51.18M
Total Assets Q3 2025 · Sep 30, 2025 $40.9M
Total Assets Q3 2025 · Dec 31, 2024 $54.13M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.03
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.03
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$4.88
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$12.96
Eps Basic Q3 2025 · Sep 30, 2025 −$0.03
Eps Basic Q3 2025 · Sep 30, 2025 −$1.03
Eps Basic restated Q3 2025 · Sep 30, 2024 −$4.88
Eps Basic restated Q3 2025 · Sep 30, 2024 −$12.96
Sga Expense Q3 2025 · Sep 30, 2025 $9.4M
Sga Expense Q3 2025 · Sep 30, 2025 $27.1M
Sga Expense Q3 2025 · Sep 30, 2024 $16.08M
Sga Expense restated Q3 2025 · Sep 30, 2024 $48.94M
Rd Expense Q3 2025 · Sep 30, 2025 $2.21M
Rd Expense Q3 2025 · Sep 30, 2025 $6.34M
Rd Expense Q3 2025 · Sep 30, 2024 $2.41M
Rd Expense restated Q3 2025 · Sep 30, 2024 $10.67M
Net Income Q3 2025 · Sep 30, 2025 −$274K
Net Income Q3 2025 · Sep 30, 2025 −$9.81M
Net Income Q3 2025 · Jun 30, 2025 $204K
Net Income Q3 2025 · Mar 31, 2025 −$9.74M
Net Income Q3 2025 · Sep 30, 2024 −$22.86M
Net Income Q3 2025 · Sep 30, 2024 −$60.38M
Net Income Q3 2025 · Jun 30, 2024 −$17.19M
Net Income Q3 2025 · Mar 31, 2024 −$20.33M
Operating Income Q3 2025 · Sep 30, 2025 $1.63M
Operating Income Q3 2025 · Sep 30, 2025 −$4.99M
Operating Income Q3 2025 · Sep 30, 2024 −$20.7M
Operating Income Q3 2025 · Sep 30, 2024 −$54.51M